| Literature DB >> 28540156 |
Abstract
OBJECTIVES: This study aimed to investigate the factors affecting the health-related quality of life (HRQOL) of patients with chronic hepatitis C (CHC).Entities:
Keywords: chronic hepatitis C; health; patient; quality of life
Year: 2017 PMID: 28540156 PMCID: PMC5441437 DOI: 10.24171/j.phrp.2017.8.2.04
Source DB: PubMed Journal: Osong Public Health Res Perspect ISSN: 2210-9099
Participants’ general and disease related characteristics (n = 125)
| Characteristic | Category | Data |
|---|---|---|
| Age (y) | 59.01 ± 9.49 | |
| ≤ 50 | 30 (24.0) | |
| ≥ 51 | 95 (76.0) | |
| Sex | Male | 66 (52.8) |
| Female | 59 (47.2) | |
| Religion | Yes | 84 (67.2) |
| No | 41 (32.8) | |
| Living type | Couple | 49 (39.2) |
| Family (with children) | 47 (37.6) | |
| Single | 29 (23.2) | |
| Educational level | Below high school | 103 (82.4) |
| Above college degree | 22 (17.6) | |
| Employment status | Employed | 48 (38.4) |
| Self-employed | 23 (18.4) | |
| Unemployed | 54 (43.2) | |
| Monthly income | Below 2,490 | 76 (60.8) |
| (×103 KRW) | 2,500–5,000 | 30 (24.0) |
| Above 5,000 | 10 ( 8.0) | |
| Others | 9 ( 7.2) | |
| Comorbidity | Yes | 64 (51.2) |
| No | 61 (48.8) | |
| Cirrhosis | Yes | 40 (32.0) |
| No | 85 (68.0) | |
| Treatment | Yes | 62 (49.6) |
| No | 63 (50.4) | |
| Infection route | Unknown | 69 (55.2) |
| Tattoo or piercing | 5 (4.0) | |
| Contaminated syringe | 26 (20.8) | |
| Acupuncture or bloodletting | 20 (16.0) | |
| Others | 5 (4.0) |
Values are presented as mean ± standard deviation or number (%).
KRW, Korean won.
Liver Disease Quality of Life degree (n = 125)
| Variable | Mean ± SD | Range | |
|---|---|---|---|
| SF-36 | Total | 72.77 ± 14.68 | 28.0–98.4 |
| Physical functioning | 82.76 ± 15.39 | 16.7–95.8 | |
| Role limitation-physical | 81.60 ± 21.77 | 6.3–100.0 | |
| Bodily pain | 83.84 ± 20.72 | 22.5–100.0 | |
| General health | 55.03 ± 16.96 | 16.7–95.8 | |
| Vitality | 51.90 ± 23.02 | 0.0–100.0 | |
| Social functioning | 79.00 ± 21.51 | 25.0–100.0 | |
| Role limitation-emotion | 80.27 ± 23.37 | 0.0–100.0 | |
| Mental health | 67.80 ± 20.32 | 10.0–100.0 | |
| LDTS | Total | 72.34 ± 10.85 | 40.1–94.5 |
| Liver disease symptoms | 85.73 ± 13.02 | 37.7–100.0 | |
| Effects of liver disease | 76.22 ± 11.54 | 31.0–100.0 | |
| Concentration | 89.71 ± 13.22 | 46.4–100.0 | |
| Memory | 89.77 ± 11.28 | 50.0–100.0 | |
| Social interaction quality | 72.56 ± 13.12 | 45.0–100.0 | |
| Health distress | 68.90 ± 20.07 | 25.0–100.0 | |
| Sexual functioning | 58.42 ± 21.59 | 0.0–100.0 | |
| Sexual problems (n = 66) | 71.01 ± 24.38 | 0.0–100.0 | |
| Sleep | 71.64 ± 18.68 | 10.0–100.0 | |
| Loneliness | 75.32 ± 16.43 | 30.0–100.0 | |
| Hopelessness | 63.60 ± 18.24 | 25.0–100.0 | |
| Liver disease stigma | 79.90 ± 18.42 | 25.0–100.0 |
SD, standard deviation; SF-36, Short Form-36; LDTS, Liver Disease-Targeted Scale.
Influencing variables of SF-36 and LDTS subareas (n = 125)
| Variable | SF-36 | LDTS | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| PF | BP | GH | VT | MH | Concentration | Sexual problems | Loneliness | Hopelessness | |
|
|
|
|
|
|
|
|
|
| |
| β ( | β ( | β ( | β ( | β ( | β ( | β ( | β ( | β ( | |
| Age (≥ 51 y) | −0.43 (< 0.001) | ||||||||
|
| |||||||||
| Sex (female) | −0.18 (0.049) | −0.35 (< 0.001) | |||||||
|
| |||||||||
| Education level (above college) | 0.21 (0.031) | ||||||||
|
| |||||||||
| Living type (single) | −0.18 (0.040) | −0.15 (0.042) | −0.29 (0.001) | ||||||
|
| |||||||||
| Employment status (unemployment) | −0.19 (0.047) | ||||||||
|
| |||||||||
| Monthly income (≥ 2,490 × 103 KRW) | −0.20 (0.034) | −0.31 (0.001) | −0.26 (0.008) | −0.28 (0.004) | |||||
|
| |||||||||
| Comorbidity (yes) | −0.23 (0.009) | −0.22 (0.016) | −0.21 (0.022) | ||||||
|
| |||||||||
| B | 103.06 | 99.08 | 60.59 | 67.86 | 70.40 | 97.41 | 144.90 | 69.72 | 53.36 |
|
| |||||||||
| SE | 7.76 | 10.51 | 8.87 | 11.40 | 10.50 | 6.80 | 17.56 | 8.44 | 9.40 |
|
| |||||||||
| Adj. R2 | 0.152 | 0.143 | 0.087 | 0.182 | 0.111 | 0.119 | 0.346 | 0.120 | 0.115 |
|
| |||||||||
| F ( | 4.17 (< 0.001) | 3.95 (0.001) | 2.70 (0.013) | 4.95 (< 0.001) | 3.21 (0.004) | 3.39 (0.002) | 10.38 (< 0.001) | 3.42 (0.002) | 3.30 (0.003) |
SF-36, Short Form-36; LDTS, Liver Disease-Targeted Scale; PF, physical function; BP, bodily pain; GH, general health; VT, vitality; MH, mental health; KRW, Korean won; B, unstandardized regression coefficients; SE, standard error; β, unstandardized regression coefficients; Adj. R2, adjusted R square.
Treated as dummy variables.